Lineage Cell Therapeutics, Inc. (TLV:LCTX)
Israel · Delayed Price · Currency is ILS · Price in ILA 589.00
+13.20 (2.29%)
Oct 30, 2025, 5:24 PM IDT
Lineage Cell Therapeutics Market Cap
Lineage Cell Therapeutics has a market cap or net worth of 1.43 billion as of October 31, 2025. Its market cap has increased by 134.49% in one year.
Market Cap
1.43B
Enterprise Value
1.30B
Revenue
36.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
589.00
Market Cap Chart
Since May 1, 1992, Lineage Cell Therapeutics's market cap has increased from 49.45M to 1.43B, an increase of 2,792.43%. That is a compound annual growth rate of 10.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 1.27B | 214.45% |
| Dec 31, 2024 | 403.42M | -41.27% |
| Dec 29, 2023 | 686.90M | -1.77% |
| Dec 30, 2022 | 699.29M | -45.56% |
| Dec 31, 2021 | 1.28B | 51.35% |
| Dec 31, 2020 | 848.66M | 84.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 76.64B |
| Danel (Adir Yeoshua) | 2.67B |
| Kamada | 1.31B |
| SofWave Medical | 1.10B |
| BrainsWay | 1.06B |
| Bait Bakfar | 1.05B |
| Ilex Medical | 730.02M |
| Novolog (Pharm-Up 1966) | 648.81M |